Corcept Therapeutics raises FY24 revenue view to $675M-$700M, consensus $661.1M
The Fly

Corcept Therapeutics raises FY24 revenue view to $675M-$700M, consensus $661.1M

Prior guidance was $640M-$670M.

Don't Miss out on Research Tools:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App